Gary Bridger
Directeur Technique/Scientifique/R&D chez LIMINAL BIOSCIENCES INC.
Fortune : 58 384 $ au 30/04/2024
Provenance du réseau au premier degré de Gary Bridger
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 29 | |
University of Manchester Institute of Science & Technology
22
| College/University | Other Consumer Services | 22 |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada.
21
| Extinct | Pharmaceuticals: Major | 21 |
| Public Company | Biotechnology | 21 | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
14
| Subsidiary | Medical Specialties | 14 |
AnorMED, Inc.
 AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases.
13
| Extinct | Pharmaceuticals: Major | 13 |
Expansion Therapeutics, Inc.
 Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
| Subsidiary | Pharmaceuticals: Major | 6 | |
Five Corners Capital, Inc.
 Five Corners Capital, Inc. Investment ManagersFinance Five Corners Capital Inc (Five Corners Capital) is a venture capital firm founded in 2013 by Kenneth Galbraith and Gary Bridger. The firm is headquartered in British Columbia, Canada.
1
| Private Company | Investment Managers | 1 |
Ventures West Management, Inc.
 Ventures West Management, Inc. Investment ManagersFinance Ventures West Management, Inc. is venture capital firm headquartered in Vancouver, British Columbia with additional offices in Toronto, Montréal and Kanata, Ontario
1
| Extinct | Investment Managers | 1 |
| Public Company | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Gary Bridger via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| CELGENE | Biotechnology | Investor Relations Contact Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| REPLIGEN CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| YARA INTERNATIONAL ASA | Chemicals: Agricultural | Human Resources Officer Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Corporate Officer/Principal Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Biotechnology | Chief Executive Officer Director/Board Member Director of Finance/CFO | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Concordia University | College/University | Undergraduate Degree Masters Business Admin | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of British Columbia | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Toronto | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree | |
| University of Montréal | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| Loughborough University | College/University | Undergraduate Degree Masters Business Admin | |
Forum Mondial de L'Economie
 Forum Mondial de L'Economie Miscellaneous Commercial ServicesCommercial Services Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Québec Bar Assoication
 Québec Bar Assoication Financial ConglomeratesFinance The Québec Bar Association is a professional organization that oversees the practice of over 29,000 lawyers in all areas of law. The organization is based in Montréal, Canada. and has subsidiaries in Canada. The mission of the association is to ensure the protection of the public, contribute to accessible and quality justice, and defend the rule of law. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| RELYPSA INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| VERASTEM, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Perelman School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Chairman Director/Board Member | |
| EPIRUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| PROFOUND MEDICAL CORP. | Medical Specialties | Director/Board Member Director/Board Member | |
Thomvest Asset Management, Inc.
 Thomvest Asset Management, Inc. Financial ConglomeratesFinance Thomvest Asset Management, Inc. operates as an investment company. The private company is based in Redwood City, CA and it is not specified if it has any subsidiaries. | Financial Conglomerates | Chief Investment Officer President Director/Board Member | |
Liminal BioSciences Ltd.
 Liminal BioSciences Ltd. BiotechnologyHealth Technology Part of Liminal R & D BioSciences, Inc., Liminal BioSciences Ltd. is a British biopharmaceutical company founded in 2015. The private company is based in Comberton, UK. The company is focused on the discovery and development of novel, small molecule drug candidates. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
ProMetic Plasma Resources, Inc.
 ProMetic Plasma Resources, Inc. Medical/Nursing ServicesHealth Services Part of Grifols SA, ProMetic Plasma Resources, Inc. operates plasma donation centers. The private company is based in Winnipeg, Canada. ProMetic Plasma Resources was acquired by Grifols Canada Therapeutics, Inc. from Kedrion SpA on January 04, 2022 for $3.13 million. | Medical/Nursing Services | Chief Executive Officer Chairman | |
| NERVGEN PHARMA CORP. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Executive Officer Chief Operating Officer | |
Fairhaven Pharmaceuticals, Inc.
 Fairhaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Fairhaven Pharmaceuticals, Inc. engages in the research and development of small molecule antagonists that target chemoattractant and activator of eosinophils, which play a key role in type 2 inflammation-driven diseases. The company was founded on May 4, 2018 and is headquartered in Laval, Canada. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Director/Board Member | |
| ZYMEWORKS INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member President Investor Relations Contact |
Statistiques
Internationale
| Etats-Unis | 30 |
| Canada | 15 |
| Royaume-Uni | 5 |
| Norvège | 2 |
| Suisse | 2 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Finance | 4 |
| Process Industries | 2 |
Opérationnelle
| Director/Board Member | 483 |
| Corporate Officer/Principal | 230 |
| Independent Dir/Board Member | 138 |
| Chairman | 86 |
| Undergraduate Degree | 82 |
Relations les plus connectées
| Insiders | |
|---|---|
| Beth Seidenberg | 39 |
| Elaine Jones | 37 |
| Simon Geoffrey Best | 32 |
| Scott Rocklage | 32 |
| Michael Wyzga | 31 |
| Ken Galbraith | 30 |
| Peter Bisgaard | 28 |
| Dan Friedberg | 26 |
| Doug Onsi | 25 |
| Alison Lawton | 24 |
| David Jeans | 24 |
| Andrew Phillips | 23 |
| Paul Johnson | 21 |
| Bruce Wendel | 19 |
| Louise Ménard | 18 |
- Bourse
- Insiders
- Gary Bridger
- Connexions Sociétés
